Evaluation of the German Short-Form Qualiveen Questionnaire
1 other identifier
observational
50
1 country
1
Brief Summary
Two questionnaires (Qualiveen full version and Qualiveen short-form (SF)), the project information and the consent form will be sent to individuals who are scheduled for an annual control at the urological out-patient clinic of the Swiss Paraplegic Centre and who fulfill the inclusion criteria. The patients will be asked to complete the two questionnaires and to bring the completed questionnaires and the signed consent form to the annual control at the Swiss Paraplegic Centre. Participants who have consented and completed the two questionnaires will receive the two questionnaires a second time 14 days later. The primary objective of this project is to validate the German version of the SF Qualiveen questionnaire. The secondary objective is to evaluate the measurement properties of the German SF Qualiveen questionnaire in comparison with the full version.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2019
CompletedFirst Posted
Study publicly available on registry
April 1, 2019
CompletedStudy Start
First participant enrolled
August 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedMay 17, 2021
May 1, 2021
1.3 years
March 29, 2019
May 14, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
total score
Total score of the Qualiveen questionnaire is the arithmetic mean of the four sub-scores. The sub-scores are assessed using a five-point Likert scale (minimum score 0, maximum score 4). The total score indicates how much quality of life is affected by bladder problems. The higher the score the more quality of life is affected.
baseline
Secondary Outcomes (8)
bother with limitations score
baseline
change in bother with limitations score
baseline; 14 days
frequency of limitations score
baseline
change in frequency of limitations score
baseline; 14 days
fears score
baseline
- +3 more secondary outcomes
Other Outcomes (5)
age (years)
baseline
gender
baseline
bladder evacuation method
baseline
- +2 more other outcomes
Study Arms (1)
neurogenic bladder
individuals with chronic (≥12 months) neurogenic lower urinary tract dysfunction due to spinal cord injury (SCI)
Interventions
Qualiveen full version questionnaire with 40 questions for assessing the quality of life in relation to bladder dysfunction in persons with neurogenic bladder
Qualiveen short-form questionnaire with 8 questions for assessing the quality of life in relation to bladder dysfunction in persons with neurogenic bladder
Eligibility Criteria
individuals with chronic (≥ 12 months) neurogenic lower urinary tract dysfunction due to SCI
You may qualify if:
- chronic (≥ 12 months) neurogenic lower urinary tract dysfunction due to SCI
- age ≥ 18 years
You may not qualify if:
- no informed consent as documented by signature
- history of concomitant neurological or psychological illness
- history of cognitive impairment
- insufficient German language skills
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, 6207, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jürgen Pannek, Prof
Schweizer Paraplegiker-Zentrum Nottwil
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2019
First Posted
April 1, 2019
Study Start
August 2, 2019
Primary Completion
November 1, 2020
Study Completion
December 31, 2020
Last Updated
May 17, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share